Invitation to presentation of Xbrane Biopharma’s Year-end report 2023 on February 26, 2024

Corporate Information





Xbrane Biopharma AB invites to a teleconference for investors, analysts and media on Monday, February 26th, 2024, at 13.00 a.m. CET. Xbrane will publish the company’s Year-end report 2023, on Monday, February 26, 2024, at 8.00 a.m. CET.

Martin Åmark, CEO, and Anette Lindqvist, CFO/IR, will present the interim Year-end report 2023, followed by a Q&A session. The presentation will be in English.

If you wish to participate via webcast, please use the link below. Via the webcast you can ask written questions.
Xbrane Biopharma Q4 Report 2023 (

If you wish to participate via teleconference, please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.

Call Access (